Pure Global AI
NCT06239038Recruitment Completed

Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty

Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty: A Randomized Controlled Trial
Police General Hospital, ThailandPhase 3ClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Osteoarthritis, Knee
Drug/Device/Intervention
total knee arthroplasty
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Police General Hospital, Thailand
Location
Pathum Wan, Thailand
Timeline & enrollment
Phase
Phase 3
Start date
Oct 11, 2021
End date
Feb 29, 2024
Enrollment
132 participants
Primary outcome

Postoperative pain (visual analog scale) day 1-4

Summary

Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis of the
 knee. The main advantages of TKA are to relieve the pain of the knee, improve the knee
 function, restore lower limb alignment, and improve the quality of life for patients. During
 TKA, some surgeons prefer using a scalpel while others using electrocautery to expose the
 articular cavity. Whether the use of scalpel can lead to better and faster recovery after the
 primary TKA is still controversial.
 
 The aim of this study was to compare the clinical outcomes of using the scalpel and the
 electrocautery in primary TKA

ICD-10 classifications
Chronic instability of kneeInjuries to the knee and lower legGonarthrosis [arthrosis of knee]Dislocation, sprain and strain of joints and ligaments of kneeSprain and strain of other and unspecified parts of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06239038
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06239038 through Pure Global AI's free database. This Phase 3 trial is sponsored by Police General Hospital, Thailand and is currently Recruitment Completed. The study focuses on Osteoarthritis, Knee. Target enrollment is 132 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.